International Immunology, Vol. 13, No. 1, 75-83,
January 2001
© 2001 Japanese Society for Immunology
CD4+Thy1- thymocytes with a Th-type 2 cytokine response
Department of Immunology, Duke University Medical Center, Box 3010, Durham, NC 27710, USA
1 Present address: Division of Biochemistry and Pharmacology, United States Army Medical Research Institute of Chemical Defense, 3100 Ricketts Point Road, APG, MD 21010-5425, USA
Correspondence to: M. Sarzotti
We have identified a small subset of CD3+, CD4+, CD8 thymocytes that do not express Thy1 (CD90). This Thy1 subset represents 13.7% of the total number of thymocytes in a naive mouse. CD4+Thy1 thymocytes express high levels of CD3, intermediate to high levels of heat-stable antigen (HSA), and low levels of CD25, CD45RB, CD69, CD44 and CD62L. They produce high titers of IL-4 and no IFN-
upon stimulation in vitro, a response characteristic of Th2 cells. In the thymi of mice infected neonatally with a high dose of the retrovirus Cas-Br-E MuLV, the frequency of CD4+Thy1 cells increased ~10-fold. High-dose virus infection resulted in decreased HSA and increased CD44 expression on CD4+Thy1 cells relative to cells from naive mice. CD4+Thy1 cells from high-dose infected mice also secreted IL-4 and not IFN-
upon in vitro stimulation. We previously reported that infection of newborn mice with a high dose of murine retrovirus results in the induction of a non-protective anti-viral Th2 T cell response; CD4+Thy1 thymocytes with a Th2-like cytokine profile may play a role in determining the cytokine bias of this anti-viral response.
Keywords: Cas-Br-E MuLV, CD4+ cells, newborn mice, Th2, Thy1 thymocytes, thymic atrophy
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. M. Wong, V. Tam, R. Lam, K. A. Walsh, L. Tatarczuch, C. N. Pagel, E. C. Reynolds, N. M. O'Brien-Simpson, E. J. Mackie, and R. N. Pike Protease-Activated Receptor 2 Has Pivotal Roles in Cellular Mechanisms Involved in Experimental Periodontitis Infect. Immun., February 1, 2010; 78(2): 629 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Fadel, L. G. Cowell, S. Cao, D. A. Ozaki, T. B. Kepler, D. A. Steeber, and M. Sarzotti Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection Int. Immunol., February 1, 2006; 18(2): 249 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Baker-LePain, M. Sarzotti, and C. V. Nicchitta Glucose-Regulated Protein 94/Glycoprotein 96 Elicits Bystander Activation of CD4+ T Cell Th1 Cytokine Production In Vivo J. Immunol., April 1, 2004; 172(7): 4195 - 4203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Fadel, D. A. Ozaki, and M. Sarzotti Enhanced Type 1 Immunity After Secondary Viral Challenge in Mice Primed as Neonates J. Immunol., September 15, 2002; 169(6): 3293 - 3300. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, K. L. Legge, B. Min, J. J. Bell, R. Gregg, J. Caprio, and H. Zaghouani Neonatal Immunity Develops in a Transgenic TCR Transfer Model and Reveals a Requirement for Elevated Cell Input to Achieve Organ-Specific Responses J. Immunol., September 1, 2001; 167(5): 2585 - 2594. [Abstract] [Full Text] [PDF] |
||||


